Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 39-43 , March 2007

The application of 5-aminolevulinic acid-induced fluorescence for cystoscopic diagnosis and treatment of bladder carcinoma

References 

  1. Schellhammer PF. Immediate adjuvant intravesical chemotherapy after transurethral resection of bladder tumor. Curr Opin Urol. 1998;8:407–409
  2. Althausen AF, Prout GR, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol. 1976;116:575–580
  3. Klan R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146:316–318
  4. Schips L, Augustin H, Zigeuner RE, et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?. Urol. 2002;59:220–223
  5. Grimm MO, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol. 2003;170:433–437
  6. Zaak D, Karl A, Knuchel R, et al. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int. 2005;96:217–222
  7. Jichlinski P. Photodynamic applications in superficial bladder cancer: facts and hopes!. J Environ Pathol Toxicol Oncol. 2006;25:441–452
  8. Zaak D. Clinical results. In:  Baumgartner R,  Kriegmair M,  Hofstadter F editor. Fluorescence diagnosis of bladder tumor using 5-aminolevulinic acid—Fundamentals and Results. Tuttlingen, Germany: Verlag Endo-Press; 2000;p. 37
  9. Olivo M, Lau W, Manivasager V, et al. Fluorescence confocal microscopy and image analysis of bladder cancer using 5-aminolevulinic acid. Int J Oncol. 2003;22:523–528
  10. Steinbach P, Kriegmair M, Baumgartner R, et al. Intravesical instillation of 5-aminolevulinic acid (5-ALA): The fluorescent metabolite is limited to urothelial cells. Urol. 1994;44:676–681
  11. Knuechel R, Turban HJ, Zaak D, et al. Die Rolle entzuendlicher urothelialer Laesionen bei der photodynamischen Diagnostik mit der 5-Aminolaevulinsaeure. Akt Urol. 1997;29:39;(in Germany)
  12. Filbeck T, Roessler W, Knuechel R, et al. 5-Aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. Urology. 1999;53:77–81
  13. Hartmann A, Moser K, Kriegmair M, et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol. 1999;154:721–727
  14. Zaak D, Frimberger D, Stepp H, et al. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection. J Urol. 2001;166:1665–1669
  15. Zaak D, Kriegmair M, Stepp H, et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology. 2001;57:690–694
  16. Zaak D, Stepp H, Baumgartner R, et al. Endoscopic detection of urinary bladder cancer with 5-Aminolevulinic acid based fluorescence endoscopy. J Urol Suppl. 1999;161:170
  17. Riedl CR, Daniltchenko D, Koenig F, et al. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol. 2001;165:1121–1123
  18. Kriegmair M, Zaak D, Rothenberger KH, et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol. 2002;168:475–478
  19. Junker K, Kania K, Fiedler W, et al. Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. Int J Oncol. 2002;20:647–653

PII: S1572-1000(06)00152-9

doi: 10.1016/j.pdpdt.2006.12.001

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 39-43 , March 2007

Article Tools

* Image Usage & Resolution